Down-regulation of MIF by NFκB under hypoxia accelerated neuronal loss during stroke

FASEB Journal

Volumn 28, Issue 10, 2014, Pages 4394-4407

  Zhang, Si ^a   Zis, Odysseus ^a   Ly, Philip T T ^a   Wu, Yili ^a   Zhang, Shuting ^a   Zhang, Mingming ^a   Cai, Fang ^a   Bucala, Richard ^b,c   Shyu, Woei Cherng ^d   Song, Weihong ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b YALE UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Caspase 3; Macrophage migration inhibitory factor; Nuclear factor B

Indexed keywords

CASPASE 3; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; ISOMERASE; MIF PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOWN REGULATION; GENE; GENE DISRUPTION; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; MOUSE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PROMOTER REGION; PROTEIN EXPRESSION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL HYPOXIA; CEREBRAL ARTERY DISEASE; GENETICS; HEK293 CELL LINE; MALE; METABOLISM; NERVE CELL; PATHOLOGY;

ANIMALS; APOPTOSIS; CELL HYPOXIA; CELLS, CULTURED; DOWN-REGULATION; HEK293 CELLS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, INBRED BALB C; NEURONS; NF-KAPPA B; OXIDATIVE STRESS;

EID: 84907710316     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-253625     Document Type: Article

References (64)

1. Donnan, G. A., Fisher, M., Macleod, M., and Davis, S. M. (2008) Stroke Lancet 371, 1612-1623
2. Broughton, B. R., Reutens, D. C., and Sobey, C. G. (2009) Apoptotic mechanisms after cerebral ischemia. Stroke 40, e331-339
3. Iadecola, C., and Anrather, J. (2011) The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796-808
4. Lipton, P. (1999) Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431-1568
5. Liu, Y., Wong, T. P., Aarts, M., Rooyakkers, A., Liu, L., Lai, T. W., Wu, D. C., Lu, J., Tymianski, M., Craig, A. M., and Wang, Y. T. (2007) NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 2846-2857
6. Amor, S., Puentes, F., Baker, D., and van der Valk, P. (2010) Inflammation in neurodegenerative diseases. Immunology 129, 154-169
7. Xiong, X., Barreto, G. E., Xu, L., Ouyang, Y. B., Xie, X., and Giffard, R. G. (2011) Increased brain injury and worsened neurological outcome in interleukin-4 knockout mice after transient focal cerebral ischemia. Stroke 42, 2026-2032
8. Ziegler, G., Freyer, D., Harhausen, D., Khojasteh, U., Nietfeld, W., and Trendelenburg, G. (2011) Blocking TLR2 in vivo protects against accumulation of inflammatory cells and neuronal injury in experimental stroke. J. Cereb. Blood Flow Metab. 31, 757-766
9. Zhang, L., Zhang, Z. G., Zhang, R. L., Lu, M., Krams, M., and Chopp, M. (2003) Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke. Stroke 34, 1790-1795
10. Lazovic, J., Basu, A., Lin, H. W., Rothstein, R. P., Krady, J. K., Smith, M. B., and Levison, S. W. (2005) Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection. Stroke 36, 2226-2231
11. Calandra, T., and Roger, T. (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3, 791-800
12. Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., and Bucala, R. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365, 756-759
13. Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., and Beach, D. H. (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 190, 1375-1382
14. Kleemann, R., Hausser, A., Geiger, G., Mischke, R., Burger-Kentischer, A., Flieger, O., Johannes, F. J., Roger, T., Calandra, T., Kapurniotu, A., Grell, M., Finkelmeier, D., Brunner, H., and Bernhagen, J. (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408, 211-216
15. Mitchell, R. A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J., and Bucala, R. (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 99, 345-350
16. Amaral, F. A., Fagundes, C. T., Guabiraba, R., Vieira, A. T., Souza, A. L., Russo, R. C., Soares, M. P., Teixeira, M. M., and Souza, D. G. (2007) The role of macrophage migration inhibitory factor in the cascade of events leading to reperfusioninduced inflammatory injury and lethality. Am. J. Pathol. 171, 1887-1893
17. Miller, E. J., Li, J., Leng, L., McDonald, C., Atsumi, T., Bucala, R., and Young, L. H. (2008) Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 451, 578-582
18. Koga, K., Kenessey, A., Powell, S., Sison, C. P., Miller, E. J., and Ojamaa, K. (2011) Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxid. Redox Signal. 14, 1191-1202
19. Nguyen, M. T., Beck, J., Lue, H., Funfzig, H., Kleemann, R., Koolwijk, P., Kapurniotu, A., and Bernhagen, J. (2003) A 16-residue peptide fragment of macrophage migration inhibitory factor, MIF-(50-65), exhibits redox activity and has MIFlike biological functions. J. Biol. Chem. 278, 33654-33671
20. Nguyen, M. T., Lue, H., Kleemann, R., Thiele, M., Tolle, G., Finkelmeier, D., Wagner, E., Braun, A., and Bernhagen, J. (2003) The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J. Immunol. 170, 3337-3347
21. Wang, L., Zis, O., Ma, G., Shan, Z., Zhang, X., Wang, S., Dai, C., Zhao, J., Lin, Q., Lin, S., and Song, W. (2009) Upregulation of macrophage migration inhibitory factor gene expression in stroke. Stroke 40, 973-976
22. Inacio, A. R., Bucala, R., and Deierborg, T. (2011) Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory/immune response during the first week after stroke. J. Neuroinflammation 8, 75
23. Inacio, A. R., Ruscher, K., Leng, L., Bucala, R., and Deierborg, T. (2011) Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke. J. Cereb. Blood Flow Metab. 31, 1093-1106
24. Paralkar, V., and Wistow, G. (1994) Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 19, 48-51
25. Bacher, M., Meinhardt, A., Lan, H. Y., Dhabhar, F. S., Mu, W., Metz, C. N., Chesney, J. A., Gemsa, D., Donnelly, T., Atkins, R. C., and Bucala, R. (1998) MIF expression in the rat brain: implications for neuronal function. Mol. Med. 4, 217-230
26. Calandra, T., Bernhagen, J., Mitchell, R. A., and Bucala, R. (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179, 1895-1902
27. Waeber, G., Thompson, N., Chautard, T., Steinmann, M., Nicod, P., Pralong, F. P., Calandra, T., and Gaillard, R. C. (1998) Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3=,5=- monophosphate responsive element-binding protein CREB in pituitary cells. Mol. Endocrinol. 12, 698-705
28. Baugh, J. A., Gantier, M., Li, L., Byrne, A., Buckley, A., and Donnelly, S. C. (2006) Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. Biochem. Biophys. Res. Commun. 347, 895-903
29. Welford, S. M., Bedogni, B., Gradin, K., Poellinger, L., Broome Powell, M., and Giaccia, A. J. (2006) HIF1alpha delays premature senescence through the activation of MIF. Genes Dev. 20, 3366-3371
30. Schreck, R., Albermann, K., and Baeuerle, P. A. (1992) Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17, 221-237
31. Baeuerle, P. A., and Henkel, T. (1994) Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179
32. Stockley, J. H., and O'Neill, C. (2007) The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain. Biochem. Soc. Trans. 35, 574-576
33. Chen, C. H., Zhou, W., Liu, S., Deng, Y., Cai, F., Tone, M., Tone, Y., Tong, Y., and Song, W. (2012) Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Int. J. Neuropsychopharmacol. 15, 77-90
34. Tong, Y., Zhou, W., Fung, V., Christensen, M. A., Qing, H., Sun, X., and Song, W. (2005) Oxidative stress potentiates BACE1 gene expression and Abeta generation. J. Neural. Transm. 112, 455-469
35. Schneider, A., Martin-Villalba, A., Weih, F., Vogel, J., Wirth, T., and Schwaninger, M. (1999) NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5, 554-559
36. Ridder, D. A., and Schwaninger, M. (2009) NF-kappaB signaling in cerebral ischemia. Neuroscience 158, 995-1006
37. Mattson, M. P., Culmsee, C., and Yu, Z. F. (2000) Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res. 301, 173-187
38. Baldwin, A. S., Jr. (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683
39. Miyamoto, S., and Verma, I. M. (1995) Rel/NF-kappa B/I kappa B story. Adv. Cancer Res. 66, 255-292
40. Huang, F. P., Wang, Z. Q., Wu, D. C., Schielke, G. P., Sun, Y., and Yang, G. Y. (2003) Early NFkappaB activation is inhibited during focal cerebral ischemia in interleukin-1beta-converting enzyme deficient mice. J. Neurosci. Res. 73, 698-707
41. Cai, F., Chen, B., Zhou, W., Zis, O., Liu, S., Holt, R. A., Honer, W. G., and Song, W. (2008) SP1 regulates a human SNAP-25 gene expression. J. Neurochem. 105, 512-523
42. Zhou, W., and Song, W. (2006) Leaky scanning and reinitiation regulate BACE1 gene expression. Mol. Cell. Biol. 26, 3353-3364
43. Ly, P. T., Wu, Y., Zou, H., Wang, R., Zhou, W., Kinoshita, A., Zhang, M., Yang, Y., Cai, F., Woodgett, J., and Song, W. (2013) Inhibition of GSK3beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J. Clin. Invest. 123, 224-235
44. Chen, C. H., Zhou, W., Liu, S., Deng, Y., Cai, F., Tone, M., Tone, Y., Tong, Y., and Song, W. (2011) Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Int. J. Neuropsychopharmacol. 18, 1-14
45. Xu, Q., Guo, H., Zhang, X., Tang, B., Cai, F., Zhou, W., and Song, W. (2012) Hypoxia regulation of ATP13A2 (PARK9) gene transcription. J. Neurochem. 122, 251-259
46. Mizue, Y., Ghani, S., Leng, L., McDonald, C., Kong, P., Baugh, J., Lane, S. J., Craft, J., Nishihira, J., Donnelly, S. C., Zhu, Z., and Bucala, R. (2005) Role for macrophage migration inhibitory factor in asthma. Proc. Natl. Acad. Sci. U. S. A. 102, 14410-14415
47. Chen, S. T., Hsu, C. Y., Hogan, E. L., Maricq, H., and Balentine, J. D. (1986) A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 17, 738-743
48. Sun, X., He, G., and Song, W. (2006) BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome. FASEB J. 20, 1369-1376
49. Stephenson, D., Yin, T., Smalstig, E. B., Hsu, M. A., Panetta, J., Little, S., and Clemens, J. (2000) Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20, 592-603
50. Niizuma, K., Endo, H., and Chan, P. H. (2009) Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J. Neurochem. 109(Suppl. 1), 133-138
51. Rassaf, T., Weber, C., and Bernhagen, J. (2014) Macrophage migration inhibitory factor in myocardial ischaemia/reperfusion injury. Cardiovasc. Res. 102, 321-328
52. Zhang, X., Deguchi, K., Yamashita, T., Ohta, Y., Shang, J., Tian, F., Liu, N., Panin, V. L., Ikeda, Y., Matsuura, T., and Abe, K. (2010) Temporal and spatial differences of multiple protein expression in the ischemic penumbra after transient MCAO in rats. Brain Res. 1343, 143-152
53. Nakayama, K. (2013) cAMP-response element-binding protein (CREB) and NF-kappaB transcription factors are activated during prolonged hypoxia and cooperatively regulate the induction of matrix metalloproteinase MMP1. J. Biol. Chem. 288, 22584-22595
54. Bakirtzi, K., Belfort, G., Lopez-Coviella, I., Kuruppu, D., Cao, L., Abel, E. D., Brownell, A. L., and Kandror, K. V. (2009) Cerebellar neurons possess a vesicular compartment structurally and functionally similar to Glut4-storage vesicles from peripheral insulin-sensitive tissues. J. Neurosci. 29, 5193-5201
55. Koga, K., Kenessey, A., Powell, S. R., Sison, C. P., Miller, E. J., and Ojamaa, K. (2011) Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxid. Redox Signal. 14, 1191-1202
56. Szeto, H. H. (2006) Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J. 8, E521-E531
57. Al-Abed, Y., Dabideen, D., Aljabari, B., Valster, A., Messmer, D., Ochani, M., Tanovic, M., Ochani, K., Bacher, M., Nicoletti, F., Metz, C., Pavlov, V. A., Miller, E. J., and Tracey, K. J. (2005) ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J. Biol. Chem. 280, 36541-36544
58. Leppa, S., and Bohmann, D. (1999) Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 18, 6158-6162
59. Wagner, E. F., and Nebreda, A. R. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549
60. Koebernick, H., Grode, L., David, J. R., Rohde, W., Rolph, M. S., Mittrucker, H. W., and Kaufmann, S. H. (2002) Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 99, 13681-13686
61. Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A., and Bucala, R. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68-71
62. Bacher, M., Deuster, O., Aljabari, B., Egensperger, R., Neff, F., Jessen, F., Popp, J., Noelker, C., Reese, J. P., Al-Abed, Y., and Dodel, R. The role of macrophage migration inhibitory factor in Alzheimer's disease. Mol. Med. 16, 116-121
63. Morand, E. F., Leech, M., and Bernhagen, J. (2006) MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat. Rev. Drug Discov. 5, 399-410
64. Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., Kooistra, T., Fingerle-Rowson, G., Ghezzi, P., Kleemann, R., McColl, S. R., Bucala, R., Hickey, M. J., and Weber, C. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-596